Task specific, convoluted multi-step, narrow AI has already revolutionized the way pharma and biotech drug developers discover novel therapies. Next up is to use AI to adhere to regulatory requirements and quality standards for meeting demand and optimizing supply chains globally. Discovery isn’t enough. We need to rapidly, equitably, and safely bring novel therapies to global markets.